Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

Allena Pharmaceuticals, Inc. ALNAQ OTC

Other OTC • Healthcare • Biotechnology • US • USD

SharesGrow Score
26/100
0/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Allena Pharmaceuticals, Inc. (ALNAQ) — Analyst outlook / Analyst consensus target is. Based on 4 analyst ratings, the consensus is neutral — 4 Hold.

ALNAQ Analyst Ratings

Hold
4
Ratings
4 Hold
Based on 4 analysts giving stock ratings to Allena Pharmaceuticals, Inc. in the past 3 months
Rating breakdown
Hold
4 100%
0%
Buy
0 analysts
100%
Hold
4 analysts
0%
Sell
0 analysts

People Also View

CMVLF
CMVLF
Cellectis S.A.
$3.08
-30.00%
 MGTA
MGTA
Magenta Therapeutics, Inc.
$0.70
-7.74%
 BITRF
BITRF
Biotron Limited
$0.03
+0.00%
 FWPAY
FWPAY
Forward Pharma A/S
$300.00
-25.09%
 CHNXF
CHNXF
ChitogenX Inc.
$0.01
+0.00%
 APTCF
APTCF
Advanced Proteome Therapeutics Corporation
$0.00
+0.00%
 MRZM
MRZM
Marizyme, Inc.
$0.00
+0.00%
 SCPS
SCPS
Scopus BioPharma Inc.
$0.00
+0.00%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message